Iroko sales and marketing update

Iroko launched Vivlodex meloxicam in the U.S. to treat osteoarthritis (OA) pain. The wholesale acquisition cost (WAC) for a 5 mg capsule, the recommended daily starting dose, is $19.80. Vivlodex is a...